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SummARY – Immunoproliferative small intestinal disease (IpSID) is a rare disorder, which 
can progress to malignancy and invasion. herein, a male patient is presented with hypoalbuminemic 
ascites and a history of chronic diarrhea five years before. Small intestinal biopsy and immunohi-
stochemical study suggested the diagnosis of IpSID; the patient was then successfully treated with 
antibiotics. Considering the favorable therapeutic response of IpSID to antibiotics during primary 
stages, clinicians should be aware of its various presentations in order to initiate treatment at an early 
stage.
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Introduction
Immunoproliferative small intestinal disease (Ip-
SID) is a rare disorder presenting with chronic or inter-
mittent diarrhea and weight loss as a nonspecific mal-
absorption syndrome1,2. Recurrent crampy abdominal 
pain seems to be the most common symptom, while 
some patients suffer from vomiting, clubbing, ab-
dominal obstructive mass, ascites, edema, low-grade 
fever, anemia, organomegaly, and lymphadenopathy. 
The exact etiology and pathogenesis of the disease re-
main unknown, but could be related to chronic intes-
tinal infestations triggering an immune proliferative 
response. lymphoepithelial lesion is characteristic for 
the disease2-4.
In this report, we present a case of IpSID with the 
main complaint of limb edema, treated with antibiotics.
Case Report
A 16-year-old male adolescent was admitted to 
the Gastroenterology ward of the Children’s medical 
Center, pediatrics Center of excellence, with a 5-year 
history of intermittent bouts of high-output diarrhea 
and crampy abdominal pain. In the last 6 months, 
he also suffered from edema in his lower extremities. 
family history was unremarkable. 
At the time of admission, his height and weight 
were 150 cm and 40 kg, respectively. on physical ex-
amination, the patient was ill, pale, and emaciated. 
he had painless pitting edema in both calves. Blood 
pressure was 100/60, and other vital signs were nor-
mal. Abdominal examination revealed a significant 
amount of ascites without hepatosplenomegaly and 
lymphadenopathy. partial parenteral nutrition was 
started and he received mineral and vitamin supple-
ments. Despite nutritional support, his weight gain 
was insignificant.
echocardiography and chest x-ray ruled out heart 
failure and primary lung disease. Cultures of stool 
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specimens were negative for Salmonella and Shigella. 
his urinalysis revealed no proteinuria. laboratory 
studies showed leukocytosis, but other parameters, in-
cluding liver enzymes, were normal. Ascites fluid pa-
rameters showed leukocyte count 20/mm3, with 75% 
(15) lymphocytes and 5 polymorphonuclear cells, and 
negative culture. The serum-ascites albumin gradient 
was 0.9 g/dl. lactate dehydrogenase (lDh) level 
was 110 Iu/l (ascitic fluid lDh/serum lDh <0.6).
Serologic and bacteriologic studies for tuberculo-
sis and human immunodeficiency virus (hIv) were 
negative.
Colonoscopic examination showed no significant 
findings, while rectal biopsy specimens showed non-
specific colitis. The gross pattern of upper gastroin-
testinal tract was normal on endoscopy. Duodenal, 
gastric, and esophageal biopsies were performed, the 
histologic review of which was suggestive of IpSID 
(figs. 1 and 2). There were overt lymphoid infiltra-
tions rather completely replacing normal structure, 
mild to moderate villous atrophy without superficial 
epithelial changes, and few eosinophils in lamina pro-
pria. no Giardia lamblia parasites were seen. Rapid 
urease test and staining for Helicobacter pylori were 
negative. Immunohistochemical staining of the speci-
mens showed that the infiltrated cells were CD20+ 
lymphocytes and negative for kappa chain, lambda 
chain, CD23 and CD5. Alpha heavy chain was nega-
tive in his blood sample. Administration of azithro-
mycin and metronidazole was introduced to be con-
tinued for 6 months. The patient was discharged after 
three weeks. his condition gradually improved in the 
first month of therapy introduction. endoscopic bi-
opsies of the duodenum after 6 months of antibiotic 
therapy showed healing of duodenal pathology. now, 
the patient’s general health is good after 10-month 
follow-up; the only complaint is his short stature that 
is under management by endocrinologists.
Discussion
According to the world health organization 
classification, IpSID is listed among the heavy chain 
diseases, as a variant of mucosa-associated lymphoid 
tissue lymphoma5. IpSID is characterized by a diffuse 
plasma cell infiltrate, mainly in the lamina propria of 
the small intestine, which can transform to malignant 
forms of lymphoma. IpSID can be classified into three 
stages: stage A, the infiltrate is confined to the bowel 
mucosa with no visible tumor; stage B, nodular mu-
cosal lymphoid infiltrates are present, with or without 
mesenteric node involvement; and stage C character-
ized by the presence of large masses and transforma-
tion to malignant lymphoma6-8.
hara et al. report a case of IpSID with protein loss 
complicated with duodenal t cell lymphoma9. The 
main compliant in our patient was edema of lower 
extremities. his response to antibiotic was excellent 
Fig. 1. (A) Duodenal mucosa with overt lymphoplasmacytic infiltration nearly replacing normal structure forming vague 
aggregates; (B) closer view of the heavy infiltrate in duodenal mucosa. The cells appear rather bland with n o features of 
malignancy.
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suggesting an early phase of the disease. The patient 
was treated with azithromycin and metronidazole due 
to the possible association between Campylobacter (C.) 
jejuni along with other microorganisms and IpSID4.
A number of laboratory tests have been proposed 
for IpSID, with a variable prevalence: an α-heavy 
chain protein with no associated light chain (40%-
100% of cases); hypoproteinemia, especially low se-
rum albumin; fat in stool; high alkaline phosphatase; 
hypocalcemia and hypomagnesemia; and low hemat-
ocrit. Radiologic findings are usually not remarkable, 
except in advanced disease with obstructive and space 
occupying lesions. Although a combination of clinical 
and laboratory findings, especially if α-heavy chain is 
present, may be highly suggestive, the definitive di-
agnosis is established based on upper endoscopy with 
small intestinal biopsies and occasionally open biop-
sies1,2,9,10. 
A regional study in tunis with a total of 21 cases 
revealed a cure rate of about 90% and 67% at 2 and 3 
years, respectively. Six patients in this group were in 
an early stage and treated with an antibiotic regimen, 
including metronidazole, tetracycline and ampicillin/
tetracycline, while the remaining 15 patients received 
chemotherapeutic agents3.
various microorganisms have been reported to be 
associated with IpSID, but documented correlation 
with a specific factor has not yet been established. In-
fection with C. jejuni has been typically described as 
an underlying microbial factor in these patients. The 
presence of this organism in intestinal tissue cultures 
and induction of remission with anti-campylobacter 
antibiotics has proposed C. jejuni as the most prob-
able agent linked to IpSID4. A support to the relation 
between C. jejuni and IpSID is provided by a study 
where the analysis of frozen intestinal tissue speci-
mens revealed campylobacter in five of seven patients 
diagnosed as IpSID10. Vibrio cholerae, Ascaris lumbri-
coides, Giardia lamblia and Strongyloides stercoralis are 
some of other microorganisms that may have a role in 
chronic antigenic stimulation11,12.
Based on the favorable therapeutic response of Ip-
SID in early stages, clinicians should consider IpSID 
as a possible cause of unexplained chronic diarrhea, 
while biopsy of the duodenum could be suggested 
when exploring patients with chronic diarrhea, even 
if biopsies are not specifically required.
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Sažetak
ImunopRolIfeRACIJSKA BoleSt tAnKoG CRIJevA mAnIfeStIRAnA ASCIteSom I eDemom
M. Shoaran, A. Khodadad, F. Mahjoub, M-A. Kiani i N. Rezaei
Imunoproliferacijska bolest tankog crijeva je rijetka bolest koja može napredovati u malignu i invazivnu bolest. prika-
zuje se slučaj bolesnika s hipoalbuminemičnim ascitesom i petogodišnjom anamnezom kroničnog proljeva. Biopsija tankog 
crijeva i imunohistokemijske pretrage upućivale su na dijagnozu imunoproliferacijske bolesti tankog crijeva, te je bolesnik 
uspješno liječen antibioticima. S obzirom na povoljan terapijski odgovor na antibiotike u ranim stadijima ove bolesti klini-
čari bi trebali poznavati njezine raznolike manifestacije kako bi pravodobno uveli primjerenu terapiju. 
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